Question

A 52-year-old man with type 2 diabetes (A1C 8.1%), ASCVD, and eGFR 62 mL/min/1.73 m2 is on metformin. What addition aligns with current standards to reduce cardiovascular risk, independent of baseline A1C?

Accepted Answer

Add an SGLT2 inhibitor or GLP-1 receptor agonist with cardiovascular benefit

Answer

Add sulfonylurea

Answer

Add basal insulin

Answer

Add a thiazolidinedione first

Answer

Focus on A1C <6.5% with no medication changes

Practice question

A 52-year-old man with type 2 diabetes (A1C 8.1%), ASCVD, and eGFR 62 mL/min/1.73 m2 is on metformin. What addition aligns with current standards to reduce cardiovascular risk, independent of baseline A1C?